Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. 1996

J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
Midwest Heart Research Foundation, Lombard, Illinois 60148, USA.

OBJECTIVE This multicenter study sought to evaluate the short-term efficacy and safety of prolonged, low dose, direct urokinase infusion in recanalization of chronically occluded saphenous vein bypass grafts in a large sample of patients, as well as to determine the 6-month patency rates for this procedure. BACKGROUND Patients with chronically occluded aortocoronary vein grafts and uncontrolled angina pectoris have limited options for therapy. Previous work has shown that chronically occluded vein grafts can be recanalized by thrombolysis. METHODS A coaxial infusion of urokinase (100,000 U/h) was given directly into occluded vein grafts in 107 patients. Balloon angioplasty was performed after lysis was achieved. Patients were discharged with warfarin and aspirin therapy. Six-month clinical follow-up data were obtained, and repeat angiography was encouraged. RESULTS Initial patency was achieved in 74 patients (69%). Mean duration of infusion was 25.4 h, and mean urokinase dosage was 3.70 million U. Acute adverse events included acute myocardial infarction in 5 patients (5%), enzyme level elevation in 18 (17%), emergency coronary artery bypass graft surgery in 4 (4%), stroke in 3 (3%) and death in 7 (6.5%). Recanalization was unsuccessful in all seven patients who died. Six-month follow-up angiograms were obtained for 40 patients (54%), 16 of whom maintained a patent graft (40%). Angina was present in 13 patients with successful (22%) and 12 with unsuccessful (71%) recanalization at 6-month follow-up. CONCLUSIONS Chronically occluded aortocoronary vein grafts can be recanalized in approximately 70% of appropriately selected patients. Complications are similar to those observed with repeat operations. Clinical follow-up shows an improvement in angina. This procedure is intended for patients with only one occluded vein graft. Strict adherence to the protocol will improve patency and reduce complications.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
September 1996, Coronary artery disease,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
July 1989, AJR. American journal of roentgenology,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
February 1987, AJR. American journal of roentgenology,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
September 1989, Catheterization and cardiovascular diagnosis,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
July 1998, Catheterization and cardiovascular diagnosis,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
November 1982, Surgery,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
December 1995, Catheterization and cardiovascular diagnosis,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
January 1988, Cardiovascular clinics,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
December 1995, Catheterization and cardiovascular diagnosis,
J R Hartmann, and L S McKeever, and W W O'Neill, and C J White, and P L Whitlow, and P S Gilmore, and A J Doorey, and J P Galichia, and E L Enger
December 1980, The Annals of thoracic surgery,
Copied contents to your clipboard!